Medicine Man Technologies, Inc.
SHWZ
$0.02
$0.01100.00%
| Weiss Ratings | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -4,900.88 | |||
| Price History | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -56.14% | |||
| 30-Day Total Return | -50.00% | |||
| 60-Day Total Return | 100.00% | |||
| 90-Day Total Return | -81.82% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -97.83% | |||
| 2-Year Total Return | -98.23% | |||
| 3-Year Total Return | -98.65% | |||
| 5-Year Total Return | -98.41% | |||
| 52-Week High % Change | -99.04% | |||
| 52-Week Low % Change | 999,900.00% | |||
| Price | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.04 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Feb 05, 2025 | |||
| 52-Week High Price (Date) | Mar 18, 2024 | |||
| Valuation | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 801.57K | |||
| Enterprise Value | 186.61M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.68 | |||
| Earnings Per Share Growth | -25.01% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.00 | |||
| Price/Book (Q) | 0.01 | |||
| Enterprise Value/Revenue (TTM) | 1.08 | |||
| Price | $0.02 | |||
| Enterprise Value/EBITDA (TTM) | 7.17 | |||
| Enterprise Value/EBIT | 36.66 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 71.68M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 303 371 0387 | |||
| Address | 865 North Albion Street Denver, CO 80220 | |||
| Website | www.schwazze.com | |||
| Country | United States | |||
| Year Founded | 2014 | |||
| Profitability | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 2.95% | |||
| Profit Margin | -20.03% | |||
| Management Effectiveness | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.93% | |||
| Return on Equity | -- | |||
| Income Statement | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 172.23M | |||
| Total Revenue (TTM) | 172.45M | |||
| Revenue Per Share | $2.41 | |||
| Gross Profit (TTM) | 76.02M | |||
| EBITDA (TTM) | 26.02M | |||
| EBIT (TTM) | 5.09M | |||
| Net Income (TTM) | -34.55M | |||
| Net Income Avl. to Common (TTM) | -34.55M | |||
| Total Revenue Growth (Q YOY) | 7.91% | |||
| Earnings Growth (Q YOY) | -7.41% | |||
| EPS Diluted (TTM) | -0.68 | |||
| EPS Diluted Growth (Q YOY) | 18.28% | |||
| Balance Sheet | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 19.71M | |||
| Cash Per Share (Q) | $0.27 | |||
| Total Current Assets (Q) | 53.67M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | 119.29M | |||
| Current Ratio (Q) | 0.968 | |||
| Book Value Per Share (Q) | $1.61 | |||
| Total Assets (Q) | 358.14M | |||
| Total Current Liabilities (Q) | 55.46M | |||
| Total Debt (Q) | 191.87M | |||
| Total Liabilities (Q) | 238.85M | |||
| Total Common Equity (Q) | 119.29M | |||
| Cash Flow | SHWZ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -26.44M | |||
| Cash from Financing (TTM) | -5.46M | |||
| Net Change in Cash (TTM) | -19.70M | |||
| Levered Free Cash Flow (TTM) | 10.41M | |||
| Cash from Operations (TTM) | 12.20M | |||
